Vor Biopharma Inc.VORNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank71
3Y CAGR-54.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-54.1%/yr
vs +360.1%/yr prior
Acceleration
-414.2pp
Decelerating
Percentile
P71
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$865000.00-
2024$0.00-100.0%
2023$3.49M-61.0%
2022$8.96M-
2021$0.00-
2020$0.00-100.0%
2019$91000.00+355.0%
2018$20000.00-